Our group demonstrated in type 1 diabetic mice that Adam17 deletion in proximal tubular cells protects from diabetic kidney lesions, suggesting a potential therapeutic strategy for the treatment of diabetic nephropathy [15]. Here, ADAM17 is linked to diabetic kidney disease.